NCT Number: NCT01173250
Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?
Total proctocolectomy with ileal pouch anal anastomosis is the first choice surgical operation for management of ulcerative colitis and familial adenomatous polyposis. The addition of diverting ileostomy may reduce septic complications. In this randomized study the investigators compare two groups of patients with stapled ileoanal pouch one of them had diverting ileostomy and in the other this step is omitted.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients having total proctocolectomy with ileal pouch anal anastomosis.
Exclusion criteria
- hypoalbuminemia
- prolonged steroid use
- anemia
- anastomosis under tension
- leak with air test
- bleeding
- poor vascular supply of anastomosis
Treatment and study plan
omitting diverting ileostomy
ProcedureInterested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Mansoura University
Other
Registry information
Important dates
- First posted
- Aug 2, 2010
- Registry last updated
- Aug 16, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Ten Versus Fifteen Centimeter Pouch in IPAA Surgery
NCT06538402
Adenoma, Adenomatous Polyposis Coli
Aarhus, Denmark
View Trial DetailsFeasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153
Colitis, Colitis, Ulcerative
Nijmegen, Netherlands
View Trial DetailsEffect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
NCT05313620
Cardiovascular Diseases, Colitis
Madrid, Spain
View Trial DetailsFilgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535
Colitis, Colitis, Ulcerative
Dothan, Alabama, United States
View Trial Details